Rheumatology is a branch of medicine that deals with the diagnosis and treatment of diseases that affect the joints, muscles, and other connective tissues. As a result, this field of medicine is constantly evolving and innovating as new treatments, medications, and therapies are introduced and studied. Rheumatology research is a vital component of this evolution, as it allows for professionals to identify new treatments and develop a better understanding of diseases. For example, research into rheumatoid arthritis has helped to identify new treatments, such as biologic medications, that have significantly improved the quality of life for those suffering from the condition. Additionally, researchers have identified genetic markers associated with rheumatoid arthritis and other autoimmune diseases, enabling doctors to diagnose and treat the condition more effectively.
Other areas of research in rheumatology include the development of better treatments for osteoarthritis and the study of scleroderma, which is an autoimmune disorder that affects the connective tissues of the body. Research into these conditions has contributed to the development of new medications and treatments that can improve the quality of life for those suffering from them.
KlinEra’s unique CRC model offers regional CRCs in the same city for each site. The utilization of these resources allows proactive study planning, start-up and patient recruitment which needs proper assessment and time for conducting Rheumatology trial. Regional CRCs supports the Rheumatology study team from the site in attaining enrolment targets and timelines.
The team here in KlinEra boasts of following specialized standard processes and services needed to execute Rheumatology trial.